<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="94088">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01907555</url>
  </required_header>
  <id_info>
    <org_study_id>OLIVIER-FAIVRE PHRC N 2012</org_study_id>
    <nct_id>NCT01907555</nct_id>
  </id_info>
  <brief_title>Clinical, Molecular and Physiopathological Study of Cohen Syndrome and Cohen-like Syndromes</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project will make it possible to better understand the natural history of Cohen Syndrom
      and the phenotypes associated with mutations in the VPS13B gene, to improve the therapeutic
      management of patients. It will also provide a better description of Cohen-like syndrome for
      genetic counselling for the families concerned.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>May 2013</start_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>spectrum of mutations VPS13B</measure>
    <time_frame>baseline</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Cohen Syndrome</condition>
  <arm_group>
    <arm_group_label>- Patients presenting Cohen syndrome and two VPS13B mutations</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients presenting Cohen syndrome without a VPS13B mutation</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients presenting neutropenia</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Cohen syndrome
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting Cohen syndrome and two VPS13B mutations

          -  who accept a clinical evaluation, and to provide at least one blood sample

          -  Patients presenting the diagnostic criteria of Cohen syndrome, but without a VPS13B
             mutation

          -  Patients presenting neutropenia or pigmentary retinopathy and at least one of the
             following signs, after exclusion of any other syndrome: mental retardation,
             microcephaly, truncal obesity

        Exclusion Criteria:

          -  - Patients who do not meet the clinical and/or molecular criteria

          -  Patients who do not wish to provide a blood sample for question 1,

          -  Patients who have not provided written informed consent,

          -  Pregnant or breast-feeding women,

          -  Persons not covered by National Health Insurance and persons under guardianship or in
             prison.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 22, 2013</lastchanged_date>
  <firstreceived_date>July 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Developmental Disabilities</mesh_term>
    <mesh_term>Mental Retardation</mesh_term>
    <mesh_term>Microcephaly</mesh_term>
    <mesh_term>Muscle Hypotonia</mesh_term>
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
